In Practise Logo
In Practise Logo - Blue
In Practise Logo
Partner Interview
Published July 26, 2024

Waters Corporation: Product Innovation, Support Services & Switching Cost

Executive Bio

Former Senior Scientist at Waters Corporation

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

I'd also like to understand a bit about vendor usage. The last interview I conducted was with someone from a smaller research laboratory who used only Waters for all his instruments. He mentioned that larger organizations often use multiple vendors. I wanted to get your perspective on this. Why would this be?

My vision is different. I work for several major pharmaceutical companies, such as AstraZeneca, a UK company. And you know, Bristol Meyers Squibb, BMS. That's not true for each of these companies. At AstraZeneca, it's mainly Agilent. At AbbVie, it's mainly Agilent, too. At BMS it's mainly Waters. The reason I said 'mainly' is because from an industrial perspective, it's easier to manage. The major reason is that chromatography systems involve complex software which is difficult to learn. When a company purchases an instrument, they also purchase the software and spend a lot of time training on both. Once the lab is comfortable using it, it's very difficult for the same group of scientists to learn another software. That's the main reason.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.